Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DEXYCU (Dexamethasone Intraocular Suspension) 9% Retrospective Study 001

NCT04290676 is registered in ClinicalTrials.gov with EyePoint Pharmaceuticals, Inc. as lead sponsor.

NCT NCT04290676
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04290676 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DEXYCU (Dexamethasone Intraocular Suspension) 9% Retrospective Study 001
Lead sponsor
EyePoint Pharmaceuticals, Inc.
Phase
Observational
Overall status
Completed
Start date
November 13, 2019
Completion date
May 1, 2020
Enrollment
527 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

cataract